Discontinuous Schedule of Bevacizumab in Colorectal Cancer Induces Accelerated Tumor Growth and Phenotypic Changes.
- DOI
- 10.1016/j.tranon.2018.01.017
- Published
- 2018 Apr
- Container
- Translational oncology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.tranon.2018.01.017,
title = {Discontinuous Schedule of Bevacizumab in Colorectal Cancer Induces Accelerated Tumor Growth and Phenotypic Changes.},
author = {Becherirat S and Valamanesh F and Karimi M and Faussat AM and Launay JM and Pimpie C and Therwath A and Pocard M},
year = {2018},
journal = {Translational oncology},
doi = {10.1016/j.tranon.2018.01.017},
url = {https://doi.org/10.1016/j.tranon.2018.01.017}
}RIS
TY - JOUR TI - Discontinuous Schedule of Bevacizumab in Colorectal Cancer Induces Accelerated Tumor Growth and Phenotypic Changes. AU - Becherirat S AU - Valamanesh F AU - Karimi M AU - Faussat AM AU - Launay JM AU - Pimpie C AU - Therwath A AU - Pocard M PY - 2018 JO - Translational oncology DO - 10.1016/j.tranon.2018.01.017 UR - https://doi.org/10.1016/j.tranon.2018.01.017 ER -
APA
S, B., F, V., M, K., AM, F., JM, L., C, P., A, T., & M, P. (2018). Discontinuous Schedule of Bevacizumab in Colorectal Cancer Induces Accelerated Tumor Growth and Phenotypic Changes.. Translational oncology. https://doi.org/10.1016/j.tranon.2018.01.017
Source records
- pubmed · retrieved 2026-09-25T10:13:11.400Z